Tata Nifty Midsmall Healthcare Index Fund - Regular Plan - Growth
Tata Asset Management Pvt Ltd
₹14.51 (+1.12%)
NAV as of 9 Oct 2026
Minimum Investment: ₹5,000
Return
12.57% Returns for 1Y
Expense ratio & Others
- Net expense ratio
- 1.12%
- Exit load
- 0%
- Lock-in
- No
- Minimum investment
- ₹5,000
- Category
- Index Funds
Expense ratio is inclusive of GST. Returns may be taxed based on the fund type and your holding period — please read the scheme-related documents and consult a tax advisor. Figures are historical and do not guarantee future results.
Fund Returns Estimator
One-time investment
₹1,000
6 months
₹1,166
Invested ₹1,000
▲+16.64%1 year
₹1,126
Invested ₹1,000
▲+12.57%
Based on the fund’s historic trailing returns — a planning illustration, not a guarantee of future results.
Invest One-TimePlan it your way
The figures above are fixed to this fund’s past returns over set periods. Use a calculator to set your own amount, tenure and expected rate of return.
Risk level
Riskometer scale
- Low
- Low to Moderate
- Moderate
- Moderate to High
- High
- Very HighThis fund
Riskometer level assigned by the fund house as per SEBI norms. It can change as the scheme’s portfolio changes.
Fund benchmark
| Primary Index Name | — |
|---|---|
| Secondary Index Name | — |
| Index Name | Nifty MidSmall Healthcare Index (TRI) |
| Weighting | 100% |
Returns
| 1Y | 3Y | 5Y | 10Y | |
|---|---|---|---|---|
| Fund returns (%) | +12.57% | — | — | — |
| Cumulative returns (%) | +12.57% | — | — | — |
Fund Manager
| Manager | Nitin Sharma |
|---|---|
| Role | Manager |
| Manager Tenure | 1.25 yrs |
About Fund
| Date of Incorporation | 26 Apr 2024 |
|---|---|
| Fund House | Tata Asset Management Pvt Ltd |
| Custodian | Standard Chartered Bank |
| Registrar / Transfer Agent | Tata Asset Management Pvt Ltd |
| Address | Standard Chartered Bank,1095 Avenue of the Americas,New York, NY 10036,USA |
Top Holdings
| Company | Weightage (%) |
|---|---|
| Max Healthcare Institute Ltd Ordinary Shares | 14.54% |
| Laurus Labs Ltd | 11.84% |
| Lupin Ltd | 7.57% |
| Aurobindo Pharma Ltd | 7.09% |
| Fortis Healthcare Ltd | 6.16% |
| Glenmark Pharmaceuticals Ltd | 5.40% |
| Alkem Laboratories Ltd | 4.78% |
| Mankind Pharma Ltd | 4.36% |
| Ipca Laboratories Ltd | 4.11% |
| Biocon Ltd | 3.96% |
| Gland Pharma Ltd | 3.55% |
| Krishna Institute of Medical Sciences Ltd | 3.19% |
| Aster DM Healthcare Ltd Ordinary Shares | 3.14% |
| J.B. Chemicals & Pharmaceuticals Ltd | 2.99% |
| Abbott India Ltd | 2.82% |
Investment Strategy
The investment objective of the scheme is to provide returns, before expenses, that are in line with the performance of Nifty MidSmall Healthcare Index (TRI), subject to tracking error.
Long Term Capital Appreciation
Mutual fund investments are subject to market risks. Read all scheme-related documents carefully. The data shown is for information only and does not constitute investment advice.